Held in collaboration with
Under the auspices of
LATIN-AMERICA PROGRAMME
6TH ESO-ESMO LATIN-AMERICAN MASTERCLASS IN
CLINICAL ONCOLOGY
22-26 April 2020Buenos AiresArgentina Chairs:A. Cervantes, ES - N. Pavlidis, GRR.A. Stahel, CH
Scientific Co-ordinators:M. Aapro, CH - F. Cardoso, PT
MCO Buenos Aires (6 Dec)_screen 06.12.2019 10:11 Pagina 3
FOREWORDThe Masterclass is the most structured ESO educational activity whose format has been establishedand presented in Europe for over a decade. The success of the teaching method has been confirmedby the events held also in other parts of the world as well as by the three editions held in Latin America.It is with pleasure and gratefulness for the consideration of the local community, that ESO announcesthe sixth edition to be held in the region in 2020.The Masterclass offers plenary lectures discussing current issues and controversies as well as criticallyreviewing significant therapeutic developments. State-of-the-art data recognized by ESMO and otherevidence-based guidelines will be cited.Participants will deliver case presentations within tumour boards and small groups and discuss themwith the chairs and the faculty.As for all Masterclasses, the number of participants will be limited and admission will be by competitiveapplication only.Admitted participants will be granted free registration and half-board accommodation for the durationof the Masterclass.
TEACHING FORMATThe Masterclass offers plenary lectures regarding state-of-the-art clinical evaluation and treatmentswith reference to clinical guidelines and which will conclude in take-home messages. The clinical sessions will be complemented by tumour board discussions supported by regional tutors. Furthermore, participants will deliver case presentations within small groups and discuss these with thechairs and the faculty.In preparation of the attendance, participants will be requested to follow four selected e-ESO sessions(www.e-eso.net). All participants will reside at the course venue and participation is compulsory throughout the course.The Masterclass will be entirely in English and at least an intermediate level of English is necessary foradmission.
LEARNING OBJECTIVES• Improve medical oncologists’ skills• Practising case discussions• Deep focus on breast, gastro-intestinal, genitourinary, gynaecological and lung cancers• Compact update on further topics of interest
THE MASTERCLASS IS:• A 5-day residential educational event• Full immersion• Clinically-oriented• Multidisciplinary• Delivered by an international faculty of experts
IDEAL PROFILE OF THE MASTERCLASS CANDIDATE• Age between 30 and 40 years• At least 2-3 years’ experience in medical oncology • Involvement in scientific activities (desirable)• At least an intermediate level of English language (simple scientific discussion in English)• Practicing in Latin-America
LANGUAGEThe Masterclass will be held in English and translation will not be provided.
INSURANCEThe organisers bear no responsibility for untoward events in relation to the participation in the event. Participants will be advised to take out their own personal and travel insurance coverage.
CME AND ESMO MORA ACCREDITATION AND CERTIFICATESApplication for CME recognition will be submitted to the Accreditation Council of Oncology in Europe(ACOE) and to the European Accreditation Council for Continuing Medical Education (EACCME).EACCME credits are recognised by the American Medical Association towards the Physician’s RecognitionAward (PRA). Information on the status of the applications can be obtained from the organising secretariat.Participants will be entitled to receive a certificate of attendance at the close of the event by completingthe on-line evaluation questionnaire.Furthermore, application for the ESMO-MORA points is in process.
MCO Buenos Aires (6 Dec)_screen 06.12.2019 10:11 Pagina 4
FACULTY (as of December 2019)
M.S. Aapro, Clinique de Genolier, Genolier, CH
F. Cardoso, Champalimaud Cancer Center, Lisbon, PT
F. Cavalli, Oncology Institute of Southern Switzerland, Bellinzona, CH
A. Cervantes, University Clinical Hospital, Valencia, ES
M. Chacon, Instituto Alexander Fleming, Buenos Aires, AR
G. Curigliano, European Institute of Oncology, Milan, IT
S.X. Franco, Clinical del Country, Bogota, CO
G.H. Giornelli, Instituto Alexander Fleming, Buenos Aires, AR
S. Iseas, Hospital Udaondo, Buenos Aires, AR
D. Lorusso, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan, IT
C. Martin, Instituto Alexander Fleming, Buenos Aires, AR
N. Mottet, University Jean Monnet, Saint Etienne, FR
J. Nadal, Instituto Alexander Fleming, Buenos Aires, AR
N. Pavlidis, University Hospital, Ioannina, GR
F.A. Peccatori, European School of Oncology and European Institute of Oncology, Milan, IT
F. Penault-Llorca, Centre Jean Perrin, Clermont-Ferrand, FR
C. Rolfo, University of Maryland School of Medicine, Baltimore, US
J.P. Sadé, Instituto Alexander Fleming, Buenos Aires, AR
C. Sessa, Oncology Institute of Southern Switzerland, Bellinzona, CH
R.A. Stahel, University Hospital, Zurich, CH
E. Van Cutsem, University Hospital Gasthuisberg, Leuven, BE
J.J. Zarbá, Hospital Zenon Santillan, San Miguel de Tucuman, AR
MCO Buenos Aires (6 Dec)_screen 06.12.2019 10:11 Pagina 1
PRELIMINARY PROGRAMME
Wednesday, 22 April
12:15 Welcome and introduction Chairs
12:30 Clinical session Gynaecological Cancers Chair: C. Sessa, CH Co-Chair: TBC • Pathologist's impact in gynaecological tumour F. Penault-Llorca, FR • Discussion • Ovarian Cancer: Surgical and systemic treatment D. Lorusso, IT • Discussion • Endometrial Cancer: Local and systemic treatment C. Sessa, CH • Discussion • Cervical Cancer: Local and systemic treatment D. Lorusso, IT • Discussion 14:30 Coffee break
14:50 Spotlight session • Primary and secondary prevention of cervical cancer J.J. Zarbá, AR • Discussion 15:20 Selected participants present their national situation • How is cancer treated in my country • Discussion
15:40 Tumour board Gynaecological Cancer C. Sessa,CH - D. Lorusso, IT • Participants' case presentations Local tutor: G. Giornelli, AR
16:40 Group sessions • Clinical case presentations by participants
Chairs 1: C. Sessa, CH - Co-chair: TBC Chair 2: D. Lorusso, IT - Co-chair: TBC
17:40 The role of surgery in ovarian cancer - Video session • Discussion
20:00 Welcome dinner
Thursday, 23 April
8:30 Clinical session Breast cancer (I) Chair: F. Cardoso, PT - Co-Chair: TBC • What the clinician needs to know about breast
pathology and sample quality F. Penault-Llorca, FR • Genomic tests in clinical practice F. Cardoso, PT • Discussion • (Neo-) adjuvant chemotherapy and biological agents G. Curigliano, IT • Discussion • Neoadjuvant/adjuvant endocrine therapy F. Cardoso, PT
• Discussion
10:35 Coffee break
MCO Buenos Aires (6 Dec)_screen 06.12.2019 10:11 Pagina 5
W C
C C • F • • D • • C • • D • C
S • J • S • •
T C • L
G •
C C
T •
2 W
C C •
F • F • • G • •
•
C
10:50 Spotlight session • The reality of clinical trials in Latin America C. Rolfo, US • Discussion
11:20 Clinical session Breast cancer (II) Chair:C. Curigliano - Co-Chair: TBC • Recommended management of HER-2+ advanced
breast cancer F. Cardoso, PT • Discussion • Recommended management for triple-negative
advanced breast cancer G. Curigliano, IT • Discussion • Recommended management for ER+ advanced
breast cancer S.X. Franco. CO • Discussion 13:05 Lunch 14:00 Tumour board Breast cancer F. Cardoso, PT - G. Curigliano, IT
• Participant's case presentations S.X. Franco, CO Local tutor: J. Nadal, AR 16:00 Coffee break
16:15 Group sessions • Clinical case presentations by participants
Chair 1: F. Cardoso, PT - Co-Chair: J. Nadal, AR Chair 2 : G. Curigliano, IT - S.X. Franco, CO
18:00 Spotlight session • Fertility preservation and pregnancy in cancer patients F. Peccatori, IT • Discussion
Friday, 24 April 8:30 Clinical session Lung cancer Chair: R. Stahel, CH Co-Chair: C. Rolfo, US • Advanced NSCLC with oncogenic driver mutation C. Rolfo, US • Discussion • Advanced NSCLC without oncogenic driver mutation R. Stahel, CH • Discussion • Mutimodality treatment of stage III and oligometastatic
NSCLC C. Rolfo, US • Discussion • Multimodality therapy of small cell lung cancer R. Stahel, CH • Discussion 10:30 Coffee break
10:50 Selected participants present their national situation • How is cancer treated in my country 11:00 Discussion
11:10 Tumour board Lung cancer R. Stahel, CH - C. Rolfo, US • Participant's case presentations C. Martin, AR
MCO Buenos Aires (6 Dec)_screen 06.12.2019 10:12 Pagina 6
13:00 Lunch 14:00 Spotlight session • Title to be confirmed F. Cavalli, CH • Discussion 14:35 Group sessions Chair 1: R. Stahel, CH - Co-Chair: C. Martin, AE Chair 2: C. Rolfo, US - TBC • Clinical case presentations by participants
16:35 Coffee break
16:55 Spotlight session • How to fight financial toxicity R. Stahel, CH • Discussion
17:30 Spotlight session • Cancer of unknown primary N. Pavlidis, GR • Discussion
Saturday, 25 April 8:30 Clinical session Gastro-intestinal tumours Chair: E. Van Cutsem, BE Co-chair: A. Cervantes, ES • What you have to obtain from the pathologists to make
a good treatment decision F. Penault-Llorca, FR • Discussion • Adjuvant and neo-adjuvant treatment of colorectal cancer E. Van Cutsem, BE • Discussion • Systemic treatment in advanced CRC E. Van Cutsem, BE • Discussion • Management of early rectal Cancer A. Cervantes, ES • Discussion 10:30 Coffee break
• Treatment of early esophageal and gastric cancer A. Cervantes, ES • Discussion • Systemic treatment of advanced gastric cancers E. Van Cutsem, BE • Discussion • Systemic treatment of pancreatic and biliary tract cancer E. Van Cutsem, BE • Discussion 12:20 Selected participants present their national situation
• How is cancer treated in my country • Discussion 12:40 Tumour boardGastro-intestinal tumours A. Cervantes, ES - E. Van Cutsem, BE Tutor: S. Iseas, AR
13:40 Lunch
MCO Buenos Aires (6 Dec)_screen 06.12.2019 10:12 Pagina 7
1 L 1 S • F • 1 G C C • C
1 C
1 S • R •
1 S • N •
8 C C •
F • • E • • E • • A • 1
• A • D • E • D • E • D 1 S
• • 1 T A T
1 L
14:30 Spotlight session • Principles of geriatric oncology M. Aapro, CH • Discussion 15:00 Group sessions
Chair 1: A. Cervantes, ES - Co-chair: S. Iseas, AR Chair 2: E. Van Cutsem, BE - Co-chair: TBC • Clinical case presentations by participants 17:00 Coffee break
17:20 Spotlight session • How to operate colon cancer (video) • Discussion
20:15 Farewell dinner
Sunday, 26 April
8:00 Clinical session Genito-urinary Cancers Chair: N. Mottet, FR, BE - Co-chair: J.P. Sadé • Management of localized prostate cancer N. Mottet, FR • Discussion • Treatment of metastatic castration sensitive prostate cancer J.P. Sadè, AR • Discussion • Castration-resistant prostate cancer N. Mottet, FR • Discussion • Treatment of bladder cancer J.P. Sadè, AR • Discussion • Metastatic renal cancer: Evidence-based treatment N. Mottet, FR • Discussion 10:30 Coffee break 10:50 Tumour board Genito-urinary cancers N. Mottet, FR - J.P. Sadè, AR – • Participant's case presentations Tutor: M. Chacon, AR 11:50 Group sessions Chair 1: N. Mottet, FR - Co-Chair: M. Chacon, AR Chair 2: J.P. Sadè, AR - Co-Chair: TBC • Clinical case presentations by participants 13:00 Learning assessment test 14:00 Closing Remarks and Awards 14:15 Lunch followed by departures
MCO Buenos Aires (6 Dec)_screen 06.12.2019 10:12 Pagina 8
GENERAL INFORMATION
HOW TO APPLYInterested oncologists should apply online at www.eso.net providing the following documents:• Letter describing motivation for attending;• Support letter from head of department or mentor;• CV with list of publications (if the list is not provided, it will be assumed that no papers have
been published);• Clinical case abstract (see below).
Clinical case abstractApplicants are requested to submit an abstract describing a clinical case related to one of thesubjects of the Masterclass (breast, gastro-intestinal, genito-urinary, gynaecological and lungcancers).It is suggested that, among the subjects of the Masterclass, the clinical case is on a tumour typethat the applicant does not see frequently but that could add to the overall educational contentsof the Masterclass. On the contrary, it is recommended that the case reflects the participant’sdaily practice, avoiding uncommon or extremely rare cases which may have a lower educationalimpact.The clinical case abstract should include diagnostic considerations, treatment, results and follow-up, at least three questions proposed for discussion.Admitted participants will have the opportunity to present the clinical case in the format of a clinical grand round discussion to the chairs, tutors, other faculty members and participants. The one-page abstract should be submitted on-line using the template available atwww.eso.net, or by entering it in the application form.
The application outcome will be notified by e-mail by begin of February.
ORGANISING SECRETARIAT European School of OncologyPiazza Indipendeza 2 | 6500 Bellinzona | SwitzerlandLuis CarvalhoPh: +41 91 820 09 58 | E-mail: [email protected]
ATTENDANCE TO THE MASTERCLASS IS BY APPLICATION ONLYSuccessful applicants are granted free registration and accommodation
APPLICATION DEADLINE: 12 JANUARY 2020Information and online application are available at www.eso.net
MCO Buenos Aires (6 Dec)_screen 06.12.2019 10:11 Pagina 2
